• This topic is empty.
Viewing 0 reply threads
  • Author
    • #15187

      The European Commission has approved Kalydeco (ivacaftor) to treat children and adolescents with CF who carry the R117H mutation in the CFTR gene. Read more here.

      What do you think of this news?

Viewing 0 reply threads
  • You must be logged in to reply to this topic.

©[current-year] KLEO Template a premium and multipurpose theme from Seventh Queen